Milestone Scientific (MLSS) Net Income towards Common Stockholders (2010 - 2026)

Milestone Scientific (MLSS) has 17 years of Net Income towards Common Stockholders data on file, last reported at -$839853.0 in Q1 2026.

• For the quarter ending Q1 2026, Net Income towards Common Stockholders rose 57.89% year-over-year to -$839853.0; the trailing twelve-month figure through Mar 2026 stood at -$4.6 million (up 13.29% YoY), and the FY2025 full-year result was -$5.7 million, down 21.61% from the prior year.
• Net Income towards Common Stockholders climbed to -$839853.0 in Q1 2026, from -$1.1 million in the prior quarter.
• In the past five years, Net Income towards Common Stockholders ranged from a high of $223638.0 in Q2 2024 to a low of -$2.9 million in Q2 2022.
• A 5-year average of -$1.6 million and a median of -$1.5 million in 2025 frame the typical range for Net Income towards Common Stockholders.
• Across the five-year window, Net Income towards Common Stockholders soared 110.03% in 2024 and plunged 763.17% in 2025, its largest moves.
• Tracing MLSS's Net Income towards Common Stockholders over 5 years: stood at -$2.0 million in 2022, then advanced by 1.52% to -$2.0 million in 2023, then retreated by 4.03% to -$2.0 million in 2024, then surged by 46.42% to -$1.1 million in 2025, then grew by 22.99% to -$839853.0 in 2026.
• Business Quant data shows MLSS's Net Income towards Common Stockholders at -$839853.0 in Q1 2026, -$1.1 million in Q4 2025, and -$1.2 million in Q3 2025.